TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2017

Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy.

Martin Chasen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.